SCHEMBL17589271

SCHEMBL17589271

CC1(C(=O)Oc2ccccc2)COC(=O)OC1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.50
POLB P06746 1/20 0.50
ATM Q13315 2/20 0.37
MAPT P10636 3/20 0.36
TDP1 Q9NUW8 2/20 0.36
KDM4E B2RXH2 2/20 0.36
GAA P10253 1/20 0.36
ALDH1A1 P00352 2/20 0.35
ELANE P08246 2/20 0.34
HPGD P15428 1/20 0.34
ALOX15 P16050 1/20 0.34
HSD17B10 Q99714 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
FAAH O00519 1/20 0.34
MAOB P27338 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20848344 0.92 POLB (0.40) L3MBTL1POLBATMMAPTTDP1
SCHEMBL20848342 0.87 POLB (0.38) L3MBTL1POLBATMMAPTTDP1
SCHEMBL20848640 0.82 MAPT (0.38) L3MBTL1POLBMAPTTDP1GAA
SCHEMBL18259718 0.81 L3MBTL1 (0.51) L3MBTL1POLBATMMAPTTDP1
SCHEMBL27890730 0.78 L3MBTL1 (0.54) L3MBTL1POLBATMMAPTTDP1
SCHEMBL24885614 0.77 ESR1 (0.39) L3MBTL1POLBATMKDM4EALDH1A1
SCHEMBL846827 0.77 ALDH1A1 (0.47) L3MBTL1TDP1ALDH1A1KMT2A
SCHEMBL14967776 0.76 L3MBTL1 (0.59) L3MBTL1POLBATMMAPTTDP1
SCHEMBL27796546 0.76 L3MBTL1 (0.48) L3MBTL1POLBATMMAPTTDP1
SCHEMBL23747260 0.75 KMT2A (0.46) L3MBTL1POLBMAPTTDP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190127523-A1 POLYMERIC NANOGELS WITH DEGRADABLE BACKBONES AND FROM GRAS COMPONENTS, AND COMPOSITIONS AND METHODS THEREOF UNIV MASSACHUSETTS (US) 2019-05-02 US disclosed
US-20180134845-A1 POLYMERIC NANOGELS WITH DEGRADABLE BACKBONES AND FROM GRAS COMPONENTS, AND COMPOSITIONS AND METHODS THEREOF UNIV MASSACHUSETTS (US) 2018-05-17 US disclosed
US-20180134845-A1 POLYMERIC NANOGELS WITH DEGRADABLE BACKBONES AND FROM GRAS COMPONENTS, AND COMPOSITIONS AND METHODS THEREOF UNIV MASSACHUSETTS (US) 2018-05-17 US disclosed
US-9868821-B2 Polymeric nanogels with degradable backbones and from gras components, and compositions and methods thereof UNIVERSITY OF MASSACHUSETTS (US) 2018-01-16 US disclosed
US-9868821-B2 Polymeric nanogels with degradable backbones and from gras components, and compositions and methods thereof UNIVERSITY OF MASSACHUSETTS (US) 2018-01-16 US disclosed
US-20160075829-A1 POLYMERIC NANOGELS WITH DEGRADABLE BACKBONES AND FROM GRAS COMPONENTS, AND COMPOSITIONS AND METHODS THEREOF UNIV MASSACHUSETTS (US) 2016-03-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160075829-A1 POLYMERIC NANOGELS WITH DEGRADABLE BACKBONES AND FROM GRAS COMPONENTS, AND COMPOSITIONS AND METHODS THEREOF CD44, PGLS, HPSE L3MBTL1 2783/4885POLB 3936/4885ATM 2739/4885
US-20180134845-A1 POLYMERIC NANOGELS WITH DEGRADABLE BACKBONES AND FROM GRAS COMPONENTS, AND COMPOSITIONS AND METHODS THEREOF CD44, PGLS, HPSE L3MBTL1 2783/4885POLB 3936/4885ATM 2739/4885
US-20190127523-A1 POLYMERIC NANOGELS WITH DEGRADABLE BACKBONES AND FROM GRAS COMPONENTS, AND COMPOSITIONS AND METHODS THEREOF CD44, PGLS, HPSE L3MBTL1 2783/4885POLB 3936/4885ATM 2739/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.